What Is the Treatment for AIDS-Related Kaposi Sarcoma?
AIDS-related Kaposi sarcoma develops in the context of HIV-driven immune deficiency. The primary therapeutic goal is to restore immune function by achieving durable suppression of HIV viral load, which in turn allows most KS lesions to stabilize or resolve.
Treatment Goals
Sustained reduction of HIV viral load below the limit of detection; with immune reconstitution, most KS lesions stabilize or heal completely.
Treatment Approach — Partial Overview
Management centers on antiretroviral therapy as the cornerstone intervention; for individual lesions that are symptomatic or functionally impairing, local treatment may be considered alongside systemic care. The complete sequenced protocol is available below.
References
DOI: 10.1111/ddg.14788
- In all ART-naive HIV patients, the immediate initiation of ART is the first priority, and in the case of pretreatment and viremia, the optimization of ART by switching or intensifying it after resistance testing according to the recommendations of the guidelines of the German and the European AIDS Society.
- Especially in the case of only mild KS infestation, additional specific KS therapy is rarely required in addition to ART.
- Numerous local treatment options are available for the treatment of individual cutaneous KS lesions, ranging from camouflage, excision, cryotherapy, radiotherapy or intralesional injections of chemotherapeutic agents, to topical therapies with various externals, which can also be used in combination.
- Local and systemic KS therapies can be combined.
- Sustained reduction of HIV viral load below the limit of detection through reliable use of effective ART is essential to improve the prognosis.
- With a decrease of the HI viral load and the onset of immune reconstitution, most lesions stabilize or even heal completely.
View source ↗